Status:
COMPLETED
Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Indiana University Health
Conditions:
Advanced Cancer
Metastatic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test a spiritual care intervention for adults with advanced cancer and their caregivers. This intervention will assess 4 areas of spiritual experience: meaning and purp...
Detailed Description
Several studies have shown that cancer affects multiple dimensions of a patient's life as well as the lives of caregivers and others close to the patient who, when faced with life crises, may use reli...
Eligibility Criteria
Inclusion
- Patient is at least 18 years of age.
- Patient is at least 2 weeks post-diagnosis of an incurable and advanced stage (IV) lung, colorectal, GI neuroendocrine and Hepatobiliary, testicular and esophageal solid malignancy and receiving cancer care at IU Simon Cancer Center.
- Patient is willing and able to consent, has a reliable phone and willing to participate in 4 sessions of 30 (+/- 5) minutes per session.
- Patient has a family member or eligible friend considered to be a caregiver and interested in participating in the study.
- Patient has adequate English fluency for completion of data collection.
- Family Caregiver (FCG) is at least 18 years of age.
- Family Caregiver (FCG) has been invited to participate in the trial with a patient who meets eligibility criteria above.
- Family Caregiver (FCG) is willing and able to consent and to participate in 4 sessions of 30 (+/- 5) minutes per session
- Family Caregiver (FCG) has adequate English fluency for completion of data collection.
Exclusion
- Patient makes 3 or more errors on a validated 6-item cognitive screener (Appendix A) or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
- Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation).
- Family Caregiver (FCG) exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
Key Trial Info
Start Date :
December 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2019
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT03823313
Start Date
December 10 2018
End Date
August 28 2019
Last Update
February 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Melvin & Bren Simon Cancer Center
Indianapolis, Indiana, United States, 46202